NZ259737A - Complement-inactivating composition comprising soluble cr-1 protein and an amido-(phenyl or naphthyl) ester - Google Patents
Complement-inactivating composition comprising soluble cr-1 protein and an amido-(phenyl or naphthyl) esterInfo
- Publication number
- NZ259737A NZ259737A NZ259737A NZ25973794A NZ259737A NZ 259737 A NZ259737 A NZ 259737A NZ 259737 A NZ259737 A NZ 259737A NZ 25973794 A NZ25973794 A NZ 25973794A NZ 259737 A NZ259737 A NZ 259737A
- Authority
- NZ
- New Zealand
- Prior art keywords
- apan
- protein
- ester
- soluble
- complement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939301289A GB9301289D0 (en) | 1993-01-22 | 1993-01-22 | Novel composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ259737A true NZ259737A (en) | 1997-04-24 |
Family
ID=10729169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ259737A NZ259737A (en) | 1993-01-22 | 1994-01-21 | Complement-inactivating composition comprising soluble cr-1 protein and an amido-(phenyl or naphthyl) ester |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0680332A1 (https=) |
| JP (1) | JPH08505867A (https=) |
| CN (1) | CN1118141A (https=) |
| AU (1) | AU5863694A (https=) |
| CA (1) | CA2153797A1 (https=) |
| GB (1) | GB9301289D0 (https=) |
| NZ (1) | NZ259737A (https=) |
| TW (1) | TW241203B (https=) |
| WO (1) | WO1994016719A1 (https=) |
| ZA (1) | ZA94398B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09504524A (ja) * | 1993-10-21 | 1997-05-06 | ジー．ディー．サール アンド カンパニー | 酸化窒素シンターゼ阻害剤として有用なアミジノ誘導体 |
| GB9604518D0 (en) * | 1996-03-02 | 1996-05-01 | Smithkline Beecham Plc | Novel compounds |
| US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| JP4897690B2 (ja) * | 2004-10-12 | 2012-03-14 | ジェネンテック， インコーポレイテッド | 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
| GB2095239B (en) * | 1981-02-27 | 1985-03-06 | Torii & Co Ltd | Novel amidine compounds |
| JPS57179147A (en) * | 1981-04-28 | 1982-11-04 | Torii Yakuhin Kk | Amidine derivative |
| US5256642A (en) * | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
| AU9149791A (en) * | 1990-12-06 | 1992-07-08 | T Cell Sciences, Inc. | Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
-
1993
- 1993-01-22 GB GB939301289A patent/GB9301289D0/en active Pending
-
1994
- 1994-01-20 ZA ZA94398A patent/ZA94398B/xx unknown
- 1994-01-21 NZ NZ259737A patent/NZ259737A/en unknown
- 1994-01-21 CA CA002153797A patent/CA2153797A1/en not_active Abandoned
- 1994-01-21 EP EP94904705A patent/EP0680332A1/en not_active Withdrawn
- 1994-01-21 WO PCT/GB1994/000122 patent/WO1994016719A1/en not_active Ceased
- 1994-01-21 AU AU58636/94A patent/AU5863694A/en not_active Abandoned
- 1994-01-21 CN CN94191260A patent/CN1118141A/zh active Pending
- 1994-01-21 JP JP6516809A patent/JPH08505867A/ja active Pending
- 1994-01-24 TW TW083100558A patent/TW241203B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2153797A1 (en) | 1994-08-04 |
| WO1994016719A1 (en) | 1994-08-04 |
| GB9301289D0 (en) | 1993-03-17 |
| ZA94398B (en) | 1994-11-15 |
| TW241203B (https=) | 1995-02-21 |
| JPH08505867A (ja) | 1996-06-25 |
| AU5863694A (en) | 1994-08-15 |
| EP0680332A1 (en) | 1995-11-08 |
| CN1118141A (zh) | 1996-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0661992B1 (en) | Pharmaceutical formulations of interleukin-1 inhibitors | |
| EP2371857A1 (en) | Factor XII inhibitors for treating interstitial lung disease | |
| KR20000022371A (ko) | 트롬빈 저해제와 엔도겐 담체의 결합체 | |
| TW200302105A (en) | Use of PDE5 inhibitors in the treatment of scarring | |
| SK7502002A3 (en) | Pharmaceutical combinations | |
| NZ259737A (en) | Complement-inactivating composition comprising soluble cr-1 protein and an amido-(phenyl or naphthyl) ester | |
| Marik et al. | Delayed hypersensitivity reaction to vancomycin | |
| US20120020923A1 (en) | Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents | |
| US6335330B1 (en) | Crystalline pharmaceutical product | |
| US8476249B2 (en) | Method of treating thrombocytopenia | |
| WO2010129738A1 (en) | Method of treating thrombocytopenia | |
| Enkhbaatar et al. | Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide | |
| JPH03133927A (ja) | 虚血後の心筋機能障害の改善剤 | |
| ES2271083T3 (es) | Nuevos compuestos. | |
| CA2476446A1 (en) | Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases | |
| US20040097583A1 (en) | Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders | |
| CN121752271A (zh) | 在疾病治疗中使用的稠合哌啶基二环化合物和相关化合物 | |
| WO2004035048A1 (ja) | 肝繊維化抑制剤 | |
| JPH07267857A (ja) | 新規な炎症細胞の活性化抑制剤 | |
| JP2000007562A (ja) | レトロウイルス感染に伴う免疫不全発症予防薬及び進行抑制薬 | |
| Telen | GMI-1070 | |
| Mediolanum et al. | INTROS | |
| HK1097755A (en) | Pharmaceutical combinations comprising a p2t receptor antagonist and another antithrombotic agent |